Tissue engineering approaches to cell-based type 1 diabetes therapy
about
Enzymatically degradable poly(ethylene glycol) hydrogels for the 3D culture and release of human embryonic stem cell derived pancreatic precursor cell aggregatesIntra-islet endothelial cell and β-cell crosstalk: Implication for islet cell transplantation.Generation of insulin-producing cells from human adipose-derived mesenchymal stem cells on PVA scaffold by optimized differentiation protocol.Differentiation of conjunctiva mesenchymal stem cells into secreting islet beta cells on plasma treated electrospun nanofibrous scaffold.Cluster-assembled zirconia substrates promote long-term differentiation and functioning of human islets of Langerhans.
P2860
Tissue engineering approaches to cell-based type 1 diabetes therapy
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tissue engineering approaches to cell-based type 1 diabetes therapy
@ast
Tissue engineering approaches to cell-based type 1 diabetes therapy
@en
Tissue engineering approaches to cell-based type 1 diabetes therapy
@nl
type
label
Tissue engineering approaches to cell-based type 1 diabetes therapy
@ast
Tissue engineering approaches to cell-based type 1 diabetes therapy
@en
Tissue engineering approaches to cell-based type 1 diabetes therapy
@nl
prefLabel
Tissue engineering approaches to cell-based type 1 diabetes therapy
@ast
Tissue engineering approaches to cell-based type 1 diabetes therapy
@en
Tissue engineering approaches to cell-based type 1 diabetes therapy
@nl
P2093
P2860
P1476
Tissue engineering approaches to cell-based type 1 diabetes therapy
@en
P2093
Luke D. Amer
Melissa J. Mahoney
Stephanie J. Bryant
P2860
P304
P356
10.1089/TEN.TEB.2013.0462
P407
P577
2014-10-01T00:00:00Z